ArticleCancers2022

Novel BH4-BCL-2 Domain Antagonists Induce BCL-2-Mediated Apoptosis in Triple-Negative Breast Cancer.

Vishnupriya Kanakaveti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.